Home › Device types › LMF
Agent, Absorbable Hemostatic, Collagen Based
FDA product code LMF · Class 3 · General, Plastic Surgery
59
Registered devices
2,108
Adverse events
27
Recalls
0
510(k) clearances
Devices with this code
Gelfoam — PHARMACIA & UPJOHN COMPANY LLCSURGIFLO® Hemostatic Matrix Kit with Thrombin — Ferrosan Medical Devices A/SSURGIFOAM® Absorbable Gelatin Powder Kit — Ferrosan Medical Devices A/SFloseal Hemostatic Matrix — BAXTER HEALTHCARE CORPORATIONINSTAT* MCH Microfibrillar Collagen Hemostat — INTEGRA LIFESCIENCES PRODUCTION CORPORATIONVitagel — Stryker CorporationVitaPrep — Stryker CorporationAvitene — Davol Inc.SURGIFOAM® Absorbable Gelatin Sponge, U.S.P. Hemorrhoidectomy Sponge — Ferrosan Medical Devices A/SGEL-FLOW™ NT — PHARMACIA & UPJOHN COMPANY LLCSURGIFLO™ Hemostatic Matrix Kit with Thrombin — Ferrosan Medical Devices A/SGelfoam — PHARMACIA & UPJOHN COMPANY LLCSURGIFOAM® Absorbable Gelatin Powder — Ferrosan Medical Devices A/SGelfoam Plus — BAXTER HEALTHCARE CORPORATIONGelfoam — PHARMACIA & UPJOHN COMPANY LLCHelitene® — Integra Lifesciences CorporationGelfoam — PHARMACIA & UPJOHN COMPANY LLCVitagel — Stryker OrthobiologicsGelfoam — PHARMACIA & UPJOHN COMPANY LLCSURGIFOAM® Absorbable Gelatin Sponge, U.S.P. Oral Sponge — Ferrosan Medical Devices A/SFloseal Hemostatic Matrix — BAXTER HEALTHCARE CORPORATIONAvitene — Davol Inc.SURGIFLO® Hemostatic Matrix — Ferrosan Medical Devices A/SVitagel — Stryker Corporation
Recent recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-03-25 | Davol, Inc. | Potential for product to contain foreign matter, confirmed to be inspect fragments. |
| 2024-04-23 | Ethicon, Inc. | Some applicator tips from these lots had open seals. |
| 2023-12-06 | Baxter Healthcare Corporation | Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align wi |
| 2023-12-06 | Baxter Healthcare Corporation | Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align wi |
| 2022-05-25 | Mckesson Medical-Surgical Inc. Corporate Office | Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lot |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the produc |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the produc |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the produc |
| 2013-03-28 | Integra LifeSciences Corporation | Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the produc |
| 2012-10-24 | Superstat Corp | The recall was initiated because Superstat Corporation has confirmed that no documentation are available to verify that quarterly dose sterility audits were per |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsSourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.